Evidence map›Paper›PMID 18160969›Full record

ArticleMaterials science & engineering. R, Reports : a review journal2007

Infectious Disease: Connecting Innate Immunity to Biocidal Polymers.

Gregory J Gabriel, Abhigyan Som, Ahmad E Madkour, Tarik Eren, Gregory N Tew

Open access · greenAbstract read
In one paragraph

Article in Materials science & engineering. R, Reports : a review journal, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 261 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Synthesis of FunctionalizedPharmaceuticals (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Gregory J GabrielPolymer Science & Engineering Department, University of Massachusetts, 120 Governors Drive, Amherst, MA 01003.
Abhigyan Som
Ahmad E Madkour
Tarik Eren
Gregory N Tew
University of Massachusetts Amherst · US

Funding

Proteomics to Biomimetic Polymers: Engineering PrincipleR01EB002048 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI DEGRADO, WILLIAM F · 2003 to 2005
$1.8M
Proteomics to Biomimetic Polymers: Engineering PrincipleR01GM065803 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI DEGRADO, WILLIAM F · 2002 to 2002
$635k
NIBIB NIH HHS R01 EB002048NIGMS NIH HHS R01 GM065803
6 · The paper itself

Abstract

Infectious disease is a critically important global healthcare issue. In the U.S. alone there are 2 million new cases of hospital-acquired infections annually leading to 90,000 deaths and 5 billion dollars of added healthcare costs. Couple these numbers with the appearance of new antibiotic resistant bacterial strains and the increasing occurrences of community-type outbreaks, and clearly this is an important problem. Our review attempts to bridge the research areas of natural host defense peptides (HDPs), a component of the innate immune system, and biocidal cationic polymers. Recently discovered peptidomimetics and other synthetic mimics of HDPs, that can be short oligomers as well as polymeric macromolecules, provide a unique link between these two areas. An emerging class of these mimics are the facially amphiphilic polymers that aim to emulate the physicochemical properties of HDPs but take advantage of the synthetic ease of polymers. These mimics have been designed with antimicrobial activity and, importantly, selectivity that rivals natural HDPs. In addition to providing some perspective on HDPs, selective mimics, and biocidal polymers, focus is given to the arsenal of biophysical techniques available to study their mode of action and interactions with phospholipid membranes. The issue of lipid type is highlighted and the important role of negative curvature lipids is illustrated. Finally, materials applications (for instance, in the development of permanently antibacterial surfaces) are discussed as this is an important part of controlling the spread of infectious disease.

Identifiers

PMID18160969
PMCPMC2153456
OpenAlexW1996507856

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.